Meta-Analysis
Copyright ©The Author(s) 2015.
World J Gastroenterol. Nov 14, 2015; 21(42): 12197-12210
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12197
Table 5 Co-morbidities of patients with hepatocellular carcinoma who underwent radiofrequency ablation
AuthorYearCountryDesignAge cut offYoung, nElderly, nAlcohol (P = 0.031)
CV comorbidities (P = 0.446)
Resp comorbidities (P = 0.474)
DM (P = 0.602)
YoungElderlyYoungElderlyYoungElderlyYoungElderly
Takahashi et al[24]2010JapanProspective7535410724.9%8.4%7.9%13.1%3.4%9.3%21.4%16.8%
Mirici-Cappa et al[13]2010ItalyRetrospective7023019512.6%5.6%NANANANANANA
Nishikawa et al[25]2012JapanProspective75238130NANA15.1%34.6%13.9%25.4%34.9%28.5%
Liu et al[20]2014TaiwanProspective7533614719.0%10.0%NANANANANANA
Fujiwara et al[26]2014JapanRetrospective75104835315.9%11.9%NANANANANANA